Invention Grant
- Patent Title: Substituted bicyclic dihydropyrimidinones and their use as inhibitors of neutrophil elastase activity
-
Application No.: US14809323Application Date: 2015-07-27
-
Publication No.: US09657015B2Publication Date: 2017-05-23
- Inventor: Christian Gnamm , Ralf Anderskewitz , Holger Hoesch , Gerd Morschhaeuser , Thorsten Oost , Stefan Peters , Uwe Joerg Ries
- Applicant: Boehringer Ingelheim International GmbH
- Applicant Address: DE Ingelheim am Rhein
- Assignee: Boehringer Ingelheim International GmbH
- Current Assignee: Boehringer Ingelheim International GmbH
- Current Assignee Address: DE Ingelheim am Rhein
- Agent Michael P. Morris; Philip I. Datlow
- Priority: EP14179306 20140731
- Main IPC: C07D471/04
- IPC: C07D471/04
Abstract:
Substituted bicyclic dihydropyrimidinones of formula 1 which are inhibitors of neutrophil elastase activity and useful as medicaments for the treatment of, inter alia, COPD. Exemplary is
Public/Granted literature
- US20160039812A1 SUBSTITUTED BICYCLIC DIHYDROPYRIMIDINONES AND THEIR USE AS INHIBITORS OF NEUTROPHIL ELASTASE ACTIVITY Public/Granted day:2016-02-11
Information query
